UB Paderborn / Katalog / Suche / in CDI

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder

Drugs (New York, N.Y.), 2022-02, Vol.82 (3), p.251-274

2022

Link zum Volltext

Verfügbarkeit prüfen

Ibudilast attenuates alcohol cue–elicited frontostriatal functional connectivity in alcohol use disorder

Alcoholism, clinical and experimental research, 2021-10, Vol.45 (10), p.2017-2028

2021

Link zum Volltext

Verfügbarkeit prüfen

Alcohol use disorder (AUD) is associated with enhanced sensitivity to cellular lipopolysaccharide challenge

Alcohol, clinical & experimental research, 2023-10, Vol.47 (10), p.1859-1868

2023

Link zum Volltext

Verfügbarkeit prüfen

Immune treatments for alcohol use disorder: A translational framework

Brain, behavior, and immunity, 2021-10, Vol.97, p.349-364

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Neural Correlates of Reward and Relief Drinking

Alcoholism, clinical and experimental research, 2021-01, Vol.45 (1), p.194-203

2021

Link zum Volltext

Verfügbarkeit prüfen

Historical Oppression, Resilience, and Transcendence: Can a Holistic Framework Help Explain Violence Experienced by Indigenous People?

Social work (New York), 2017-01, Vol.62 (1), p.37-44

2017

Link zum Volltext

Verfügbarkeit prüfen

Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers

Psychopharmacology, 2022-05, Vol.239 (5), p.1387-1395

2022

Link zum Volltext

Verfügbarkeit prüfen

Alcohol Craving and Severity are Associated with Dorsal Anterior Cingulate Choline Levels in Individuals with an Alcohol Use Disorder

Alcohol and alcoholism (Oxford), 2023-05, Vol.58 (3), p.289-297

2023

Link zum Volltext

Verfügbarkeit prüfen

Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial

Trials, 2020-09, Vol.21 (1), p.779-779, Article 779

2020

Link zum Volltext

Verfügbarkeit prüfen

Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial

Translational psychiatry, 2021-06, Vol.11 (1), p.355-355, Article 355

2021

Link zum Volltext

Verfügbarkeit prüfen

Diminished cortical response to risk and loss during risky decision making in alcohol use disorder

Drug and alcohol dependence, 2021-01, Vol.218, p.108391-108391, Article 108391

2021

Link zum Volltext

Verfügbarkeit prüfen

Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers

Drug and alcohol dependence, 2021-08, Vol.225, p.108825-108825, Article 108825

2021

Link zum Volltext

Verfügbarkeit prüfen

Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study

The American journal of drug and alcohol abuse, 2023-05, Vol.49 (3), p.333-344

2023

Link zum Volltext

Verfügbarkeit prüfen

Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder

Alcohol and alcoholism (Oxford), 2022-11, Vol.57 (6), p.727-733

2022

Link zum Volltext

Verfügbarkeit prüfen

Endotoxin for Alcohol Research: A Call for Experimental Medicine Using Lipopolysaccharide Challenge

Alcohol and alcoholism (Oxford), 2021-10, Vol.56 (6), p.715-717

2021

Link zum Volltext

Verfügbarkeit prüfen

Association between impulsivity and neural activation to alcohol cues in heavy drinkers

Psychiatry research. Neuroimaging, 2019-11, Vol.293, p.110986-110986, Article 110986

2019

Link zum Volltext

Verfügbarkeit prüfen

Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology

Alcohol, clinical & experimental research, 2023-09, Vol.47 (9), p.1629-1645

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Treatments for Alcohol Use Disorder: Considering the Role of Sex and Gender

Current addiction reports, 2024-02, Vol.11 (1), p.81-93

2024

Link zum Volltext

Verfügbarkeit prüfen

Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study

Psychopharmacology, 2023-09, Vol.240 (9), p.1921-1930

2023

Link zum Volltext

Verfügbarkeit prüfen

Sex Differences in Conditioned Taste Aversion

Biological psychiatry (1969), 2020-05, Vol.87 (9), p.S221

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of alcohol, tobacco, and cannabis co-use on gray matter volume in heavy drinkers

Psychology of addictive behaviors, 2021-09, Vol.35 (6), p.1

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of Alcohol, Tobacco, and Cannabis Co-Use on Gray Matter Volume in Heavy Drinkers

Psychology of addictive behaviors, 2021-09, Vol.35 (6), p.760-768

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control

Journal of affective disorders, 2020-03, Vol.265, p.272-277

2020

Link zum Volltext

Verfügbarkeit prüfen

Behavior and Fos activation reveal that male and female rats differentially assess affective valence during CTA learning and expression

PloS one, 2021-12, Vol.16 (12), p.e0260577-e0260577

2021

Link zum Volltext

Verfügbarkeit prüfen

Probing Inflammation and Reward in Alcohol Use Disorder

Burnette, Elizabeth Mar

2023

Link zum Volltext
ProQuest

Menü

Weitere Dienste

Einstellungen

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder

Ibudilast attenuates alcohol cue–elicited frontostriatal functional connectivity in alcohol use disorder

Alcohol use disorder (AUD) is associated with enhanced sensitivity to cellular lipopolysaccharide challenge

Immune treatments for alcohol use disorder: A translational framework

Clinical and Neural Correlates of Reward and Relief Drinking

Historical Oppression, Resilience, and Transcendence: Can a Holistic Framework Help Explain Violence Experienced by Indigenous People?

Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers

Alcohol Craving and Severity are Associated with Dorsal Anterior Cingulate Choline Levels in Individuals with an Alcohol Use Disorder

Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial

Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial

Diminished cortical response to risk and loss during risky decision making in alcohol use disorder

Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers

Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study

Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder

Endotoxin for Alcohol Research: A Call for Experimental Medicine Using Lipopolysaccharide Challenge

Association between impulsivity and neural activation to alcohol cues in heavy drinkers

Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology

Pharmacological Treatments for Alcohol Use Disorder: Considering the Role of Sex and Gender

Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study

Sex Differences in Conditioned Taste Aversion

Effect of alcohol, tobacco, and cannabis co-use on gray matter volume in heavy drinkers

Effect of Alcohol, Tobacco, and Cannabis Co-Use on Gray Matter Volume in Heavy Drinkers

Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control

Behavior and Fos activation reveal that male and female rats differentially assess affective valence during CTA learning and expression

Probing Inflammation and Reward in Alcohol Use Disorder

Suchergebnisse filtern